Feasibility of proton beam therapy for reirradiation of locoregionally recurrent non-small cell lung cancer

PBT is an option for treating recurrent NSCLC. However, the rates of locoregional recurrence and distant metastasis are high and the potential for toxicity significant. The risks and benefits of PBT must be carefully weighed in each case.